In opaque and fragmented OTC markets, data quality is critical. With no central exchange and widely varying liquidity across instruments, firms rely on independent OTC pricing they can trust to support trading, risk management, valuation and regulatory reporting.
Parameta Solutions sits within the TP ICAP Group, giving it direct access to market‑leading brokerage activity from Tullett Prebon (TP) and ICAP—two of the most established and trusted names in OTC financial markets.
This matters because inter‑dealer brokers sit at the centre of price formation in OTC markets. IDBs facilitate trading between the world’s largest banks and liquidity providers, capturing real, executable pricing at the point where institutional risk is transferred. As a result, data sourced from an IDB reflects how the market actually trades, not theoretical models, indicative quotes or selectively contributed prices.
At Parameta Solutions, OTC market data quality is engineered into every stage of the data lifecycle.
In this video, Millie Whittaker, Operations Supervisory Assistant Manager discusses how Parameta delivers trusted, high quality OTC market data at scale:
1. Continuous Monitoring of Global Market
OTC markets never sleep — and neither does Parameta’s commitment to data quality. Our monitoring framework runs 24 hours a day, six days a week, providing continuous oversight whenever global markets are active.
By maintaining real‑time surveillance across every trading session, we eliminate blind spots and detect emerging issues the moment they arise. This proactive approach ensures that our clients receive accurate, dependable OTC market data at the point of use — not delayed revisions after the event.
2. Product Specific Update Frequency Controls
OTC instruments do not exhibit uniform trading behaviour, and Parameta Solutions therefore avoids any one‑size‑fits‑all update logic. Highly liquid instruments—such as G7 FX spot rates—are expected to refresh continuously, while less liquid or more structurally complex products update at far lower natural frequencies.
Parameta applies product specific update frequency parameters that reflect how each market actually trades. These controls are reviewed continuously to ensure they remain aligned with current market conditions, helping prevent stale prices while avoiding unnecessary suppression of valid data.
This approach is essential to maintaining accurate OTC market data quality across diverse asset classes.
3. Realtime Monitoring of Price Movements
Update frequency alone cannot guarantee data integrity. Parameta also monitors real-time price movements using advanced exception-detection tools designed to identify values that deviate from prevailing market conditions.
Expected price ranges are derived from both historical behaviour and intraday market activity. When a price breaches its configured thresholds, it is flagged for reviewal. This preserves genuine market volatility especially during fast‑moving conditions—while ensuring that potential anomalies are escalated, validated, or corrected before distribution.
4. Expert validation supported by technology
In OTC markets, human expertise remains essential. Parameta’s dedicated data quality team reviews flagged prices, benchmarking them against broader market and, where appropriate, validating them directly with brokers.
This combination of automation and expert oversight is particularly valuable during periods of market volatility, when prices may move sharply but still reflect real trading conditions. The approach ensures that genuine market signals are preserved, while potential anomalies are escalated and resolved before distribution—enabling Parameta to deliver reliable, independent OTC pricing without unnecessary delays or suppression of valid data.
5. Granular Data Quality Controls
What truly differentiates Parameta is the granularity of its data quality controls. Monitoring can be applied not only by product, but down to an individual field identifier (FID).
Using our aforementioned FX Spot example,, bid and ask values can be tested independently for both update frequency and price‑movement behaviour. This level of specificity allows each data point to be calibrated to its own liquidity profile and expected market dynamics — delivering the depth of customisation required by sophisticated OTC market participants.
Built for trust in OTC market data
High‑quality OTC market data demands continuous vigilance, sophisticated controls, and deep market expertise. Parameta Solutions embeds data quality at every stage of the lifecycle—combining continuous monitoring, product‑specific parameters, real‑time analytical tests, and expert human validation to ensure accuracy without compromising timeliness across interest rate swaps, options, money markets, FX, and energy and commodities.
This integrated framework empowers financial professionals worldwide with reliable insights that support trading strategies, price discovery, valuation workflows, pre and post-trade analytics, risk management and regulatory compliance.
Contact us to learn more about our OTC data products or to request a data sample.
Disclaimer
© 2026 ICAP Information Services Limited (“IISL”). This communication is provided by ICAP Information Services Limited or a member of its group (“Parameta”) and all information contained in or attached hereto (the “Information”) is for information purposes only and is confidential. Access to the Information by anyone other than the intended recipient is unauthorised without Parameta’s prior written approval. The Information may not be not used or disclosed for any purpose without Parameta’s prior written approval, including without limitation, storing, copying, distributing, licensing, selling or displaying the Information, using the Information in an application or to create derived data of any kind, co-mingling the Information with any other data or using the data for any unlawful purpose of for any purpose that would cause it to become a benchmark under any law, regulation or guidance. The Information is not, and should not be construed as, a live price, an offer, bid, recommendation or solicitation in relation to any financial instrument or investment or to participate in any particular trading strategy or constituting financial or investment advice or a financial promotion. The Information does not constitute a public offer under any applicable legislation or an offer to sell or a solicitation of an offer to buy any securities. The Information is not to be relied upon for any purpose whatsoever and is provided “as is” without warranty of any kind, either expressly or by implication, including without limitation as to completeness, timeliness, accuracy, continuity, merchantability or fitness for any particular purpose. All representations and warranties are expressly disclaimed, to the fullest extent possible under applicable law. In no circumstances will Parameta be liable for any indirect or direct loss, or consequential loss or damages including without limitation, loss of business or profits arising from the use of, any inability to use, or any inaccuracy in the Information. Parameta may suspend, withdraw or modify or change the terms of the provision of the Information at any time in its sole discretion, without notice. All rights, including without limitation intellectual property rights, in and to the Information are, and shall remain, the property of IISL or its licensors. Use of, access to or delivery of Parameta’s products and/or services requires a prior written licence from Parameta or its relevant affiliates. The terms of this disclaimer are governed by the laws of England and Wales.
